Burdette Medical Systems Overview

  • Founded
  • 1997

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Burdette Medical Systems General Information


Developer of medical devices, systems, and software for guidance and visualization of minimally invasive treatments for cancer and other diseases. The company's inter plant II system transforms brachy therapy treatment for prostate cancer using real-time intra-operative treatment guidance and 3-D visualization. Its Dynamic-Dosimetry software allows viewing actual treatment dose as the implant progresses and making changes intra-operatively. The company's strategic partners include Johns Hopkins University and Medical School, Harvard Medical School, and Provena Health.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 2110 Clearlake Boulevard
  • Suite 102
  • Champaign, IL 61822
  • United States
+1 (217) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Burdette Medical Systems Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Burdette Medical Systems‘s full profile, request access.

Request a free trial

Burdette Medical Systems Executive Team (2)

Name Title Board Seat Contact Info
Clif Burdette Ph.D President & CEO
You’re viewing 1 of 2 executive team members. Get the full list »